A framework for organizing and selecting quantitative approaches for benefit-harm assessment (Q34481196)

2 August 2017

5 references

18 June 2019

19 September 2019

28 September 2019

2 October 2020

17 October 2020

A framework for organizing and selecting quantitative approaches for benefit-harm assessment (English)

1 reference

biomedical investigative technique

2 August 2017

main subject

1 reference

19 September 2019

1 reference

28 September 2019

evidence-based medicine

1 reference

health care quality indicators

2 October 2020

1 reference

17 October 2020

1 reference

17 October 2020

Sonal Singh

2

0 references

Cynthia M. Boyd

series ordinal

5

object named as

Cynthia M Boyd

1 reference

2 August 2017

Milo A Puhan

1

1 reference

2 August 2017

Carlos O Weiss

series ordinal

3

1 reference

2 August 2017

Ravi Varadhan

series ordinal

4

1 reference

2 August 2017

publication date

19 November 2012

6 references

BMC Medical Research Methodology

2 August 2017

18 June 2019

19 September 2019

28 September 2019

2 October 2020

17 October 2020

6 references

2 August 2017

18 June 2019

19 September 2019

28 September 2019

2 October 2020

17 October 2020

12

1 reference

2 August 2017

page(s)

173

1 reference

Creative Commons Attribution 2.0 Generic

2 August 2017

copyright license

5 references

18 June 2019

19 September 2019

28 September 2019

2 October 2020

Multi-criteria clinical decision support: A primer on the use of multiple criteria decision making methods to promote evidence-based, patient-centered healthcare

17 October 2020

0 references

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

The minimal important difference of exercise tests in severe COPD.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

A review of quantitative risk-benefit methodologies for assessing drug safety and efficacy-report of the ISPOR risk-benefit management working group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

A first step to assess harm and benefit in clinical trials in one scale

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Aspirin for the prevention of cardiovascular disease: U.S. Preventive Services Task Force recommendation statement

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Are adult patients more tolerant of treatment risks than parents of juvenile patients?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

The identification of benefit in medical intervention: an overview and suggestions for process

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Shared decision-making--transferring research into practice: the Analytic Hierarchy Process (AHP).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

The minimal important difference of the hospital anxiety and depression scale in patients with chronic obstructive pulmonary disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Antithrombotic therapy in atrial fibrillation: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Crohn's disease patients' risk-benefit preferences: serious adverse event risks versus treatment efficacy.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

A quantitative approach to benefit-risk assessment of medicines - part 2: the practical application of a new model

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

A quantitative approach to benefit-risk assessment of medicines - part 1: the development of a new model using multi-criteria decision analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Assessing a structured, quantitative health outcomes approach to drug risk-benefit analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Joint distribution approaches to simultaneously quantifying benefit and risk

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Developing a quality criteria framework for patient decision aids: online international Delphi consensus process

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Treatment benefit and the risk of suicidality in multicenter, randomized, controlled trials of sertraline in children and adolescents

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Optimal management of adults with pharyngitis--a multi-criteria decision analysis

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Number needed to treat (NNT): implication in rheumatology clinical practice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Improving interpretation of clinical studies by use of confidence levels, clinical significance curves, and risk-benefit contours

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Users' guides to the medical literature: XVI. How to use a treatment recommendation. Evidence-Based Medicine Working Group and the Cochrane Applicability Methods Working Group

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

The number needed to treat: a clinically useful measure of treatment effect

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

An assessment of clinically useful measures of the consequences of treatment

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3572426

Using the incremental net benefit framework for quantitative benefit-risk analysis in regulatory decision-making--a case study of alosetron in irritable bowel syndrome

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Uncertainty in the minimum event risk to justify treatment was evaluated

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Evaluation of effectiveness: Q-TWiST. The International Breast Cancer Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Use of quality-adjusted life year weights with dose-response models for public health decisions: a case study of the risks and benefits of fish consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

A Bayesian approach to evaluating net clinical benefit allowed for parameter uncertainty

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Advances in risk-benefit evaluation using probabilistic simulation methods: an application to the prophylaxis of deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Treatment preferences and medication adherence of people with Type 2 diabetes using oral glucose-lowering agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Multiple sclerosis patients' benefit-risk preferences: serious adverse event risks versus treatment efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2288-12-173

Benefit-risk analysis: a proposal using quantitative methods

21 January 2018

1 reference

12 December 2020

Methodological issues in the application of conjoint analysis in health care

1 reference

12 December 2020

Reporting of Adverse Effects in Clinical Trials Should Be Improved

1 reference

12 December 2020

A quality-adjusted time without symptoms or toxicity (Q-TWiST) analysis of adjuvant radiation therapy and chemotherapy for resectable rectal cancer

1 reference

12 December 2020

Benefit-risk analysis: examples using quantitative methods

1 reference

12 December 2020

A new proposal for benefit-less-risk analysis in clinical trials

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2288-12-173

1 reference

Dimensions Publication ID

2 August 2017

0 references

1 reference

2 August 2017

1 reference